Reuters logo
AbbVie, Abbott duck Depakote off-label marketing case on appeal
October 12, 2017 / 11:54 PM / in 10 days

AbbVie, Abbott duck Depakote off-label marketing case on appeal

A federal appeals court on Thursday upheld the dismissal of a class action lawsuit accusing AbbVie Inc and Abbott Laboratories of violating federal racketeering laws by promoting the drug Depakote for off-label uses.

The 7th U.S. Circuit Court of Appeals in Chicago affirmed the dismissal of a class action lawsuit filed in 2013 by two healthcare plan sponsors who paid for Depakote that they said was improperly prescribed for their members.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2wSdIua

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below